자동 로그아웃 안내

로그아웃 아이콘

로그아웃 시간이 남았습니다.
로그인 시간을 연장하시겠습니까?

로그아웃을 연장하시려면 아래 연장하기 버튼을 눌러주세요.

본문 바로가기

연구소

연구논문

  • Home
  • 연구소
  • 연구논문

논문성과

암센터 국문 논문 목록
학술지 책임저자
제1저자
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor)
Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) study 김주영
(방사선의학연구과)
김주영, Semin Lee:Meesun Yoon, Hyo Kyung Lee:박은영, 유종우, 홍은경, 김태현, 김태성, 서상수, 강석범, 신혜진. Randomized multicenter phase II trial of prophylactic irradiation of para-aortic lymph nodes in advanced cervical cancer according to tumor hypoxia: Korean Radiation Oncology Group (KROG 07-01) study INTERNATIONAL JOURNAL OF CANCER. 2022-06-25; 2022; Online:Published. IF 7.316 (2021)
Meesun Yoon, Hyo Kyung Lee
Online information analysis on pancreatic cancer in Korea using structural topic model 김열
(가정의학과)
김열:Wonkwang Jo:서민지, 이나영. Online information analysis on pancreatic cancer in Korea using structural topic model SCIENTIFIC REPORTS. 2022-06-23; 2022; 12(1):10622~. IF 4.997 (2021)
Wonkwang Jo
Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder 서호경
(비뇨의학과)
서호경:이혜원2:. Clinical implications and practical considerations for poly-ADP-ribose polymerase inhibitors as a new horizon for the management of urothelial carcinoma of the bladder INVESTIGATIVE AND CLINICAL UROLOGY. 2022-06-22; 2022; 63(4):369~372. IF 1.902 (2021)
이혜원2
(비뇨의학과)
PRR16/Largen induces epithelial-mesenchymal transition through the interaction with ABI2 leading to the activation of ABL1 kinase 노승배
(암전이연구과)
노승배, Chang Hoon Lee:Gyeoung Jin Kang, Jung Ho Park:장지윤, 박미경, 이호. PRR16/Largen induces epithelial-mesenchymal transition through the interaction with ABI2 leading to the activation of ABL1 kinase BIOMOLECULES & THERAPEUTICS. 2022-06-20; 2022; 30(4):340~347. IF 4.231 (2021)
Gyeoung Jin Kang, Jung Ho Park
Snail promotes cancer cell proliferation via its interaction with the BIRC3 Boh-Ram Kim, Chang Hoon Lee
Boh-Ram Kim, Chang Hoon Lee:노승배:. Snail promotes cancer cell proliferation via its interaction with the BIRC3 BIOMOLECULES & THERAPEUTICS. 2022-06-17; 2022; 30(4):380~388. IF 4.231 (2021)
노승배
(암전이연구과)
Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population?based study 박상재
(종양외과학연구과)
박상재, Young?Joo Won:강미주:임지원, 한성식, 박형민, 김선회, 이우진, 우상명, 김태현. Distinct prognosis of biliary tract cancer according to tumor location, stage, and treatment: a population?based study SCIENTIFIC REPORTS. 2022-06-17; 2022; 12(1):10206~. IF 4.997 (2021)
강미주1
(암등록감시부)
Postoperative Complications and Their Risk Factors of Completion Total Gastrectomy for Remnant Gastric Cancer Following an Initial Gastrectomy for Cancer 류근원
(위암센터)
류근원:박신혜:엄상수, 엄방울, 윤홍만, 김영우. Postoperative Complications and Their Risk Factors of Completion Total Gastrectomy for Remnant Gastric Cancer Following an Initial Gastrectomy for Cancer JOURNAL OF GASTRIC CANCER. 2022-06-15; 2022; 22:e19~. IF 3.197 (2021)
박신혜
(외과)
Long-term Survivorship and Non-cancer Competing Mortality in Head and Neck Cancer: A Nationwide Population-Based Study in South Korea 조현순
(암관리학과)
조현순:정유석:이다혜, 정규원. Long-term Survivorship and Non-cancer Competing Mortality in Head and Neck Cancer: A Nationwide Population-Based Study in South Korea CANCER RESEARCH AND TREATMENT. 2022-06-14; 2022; Online:Published. IF 5.036 (2021)
정유석
(암데이터과학연구부)
RhoBTB3 Regulates Proliferation and Invasion of Breast Cancer Cells via Col1a1 김연재
(표적치료연구과)
김연재:김경호:. RhoBTB3 Regulates Proliferation and Invasion of Breast Cancer Cells via Col1a1 MOLECULES AND CELLS. 2022-06-14; 2022; Online:Published. IF 4.25 (2021)
김경호
(표적치료연구과)
Dose Profile Modulation of Proton Minibeam for Clinical Application 임영경
(방사선종양학과)
김상수
(방사선의학연구과)
임영경, 김상수:김명수, Ui-Jung Hwang:박경윤, 김도현, 김학수, 정종휘, 신동호, 이세병, 김주영, 김태현, 백혜정. Dose Profile Modulation of Proton Minibeam for Clinical Application CANCERS. 2022-06-11; 2022; 14(12):2888~. IF 6.575 (2021)
김명수
(양성자치료센터)